Literature DB >> 15173701

Hemodynamic-volumetric monitoring.

G Della Rocca1, M G Costa.   

Abstract

Maintenance of adequate cardiac preload is of paramount importance in the treatment of patients undergoing major surgical surgery and in the critically ill setting. The end point is to maintain the organ perfusion through volume replacement and therapy to optimize cardiac output, oxygen deliver. Various methods have been introduced into clinical practice to estimate cardiac preload. In the last 10 years the transpulmonary indicator dilution technique showed to be accurate as hemodynamic-volumetric monitoring. We briefly review the intra thoracic blood volume index as a preload index and the fluid responsiveness indexes, stroke volume variation and pulse pressure variation, available as novel parameters at the bed-side. The optimization of fluid balance and vasoactive drugs administration based on volumetric monitoring makes the transpulmonary indicator dilution technique a new option as an effective monitoring system where intravascular volume management is a primary objective.

Entities:  

Mesh:

Year:  2004        PMID: 15173701

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  3 in total

1.  Fluid responsiveness predicted by noninvasive bioreactance-based passive leg raise test.

Authors:  Brahim Benomar; Alexandre Ouattara; Philippe Estagnasie; Alain Brusset; Pierre Squara
Journal:  Intensive Care Med       Date:  2010-07-28       Impact factor: 17.440

2.  [Clinical application of blood purification in treatment of severe adenovirus pneumonia].

Authors:  Mei-Yu Yang; Xin-Ping Zhang; Jian-She Cao; Xiong Zhou; Zi-Li Cai; Xia-Yan Kang; Bo Xie; Ying Liu; Jie He; Zheng-Hui Xiao
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-10

3.  Volkman's Contracture, Persistent Limb Ischaemia, and Amputation: A Complication of Brachial Artery Catheterisation for Haemodynamic Monitoring Using PiCCO.

Authors:  Veejay Bagga; Marion Palmer; Ramesh Sadasivan; Govindan Raghuraman
Journal:  Case Rep Crit Care       Date:  2013-09-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.